27934-98-1 Usage
Description
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester is a complex organic compound with a unique chemical structure. It is characterized by its hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid core, which is esterified with a methyl group and features a β-D-Glucopyranosyloxy substituent at the 1α position. (1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester has potential applications in various fields due to its unique properties and structural features.
Uses
Used in Pharmaceutical Industry:
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester is used as a potential therapeutic agent for various medical conditions. Its unique chemical structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs.
Used in Cosmetic Industry:
In the cosmetic industry, (1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester is used as an active ingredient in skincare products. Its ability to interact with biopolymers and macromolecules may contribute to its potential anti-aging, anti-inflammatory, and skin-protective properties.
Used in Antiosteoporotic Applications:
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester is used as an antiosteoporotic agent, potentially helping to maintain bone density and strength. Its interaction with biological targets may contribute to its ability to support bone health.
Used in Anti-Inflammatory Applications:
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester is also used as an anti-inflammatory agent, potentially helping to reduce inflammation and alleviate pain associated with various conditions. Its unique structure may allow it to modulate inflammatory pathways, providing a therapeutic benefit.
Used in Drug Delivery Systems:
(1S)-1α-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7aα-hexahydro-4aα,7α-dihydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester can be employed in the development of novel drug delivery systems. Its ability to interact with various biological molecules may enable the design of targeted drug delivery systems, improving the bioavailability and therapeutic outcomes of associated drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 27934-98-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,9,3 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 27934-98:
(7*2)+(6*7)+(5*9)+(4*3)+(3*4)+(2*9)+(1*8)=151
151 % 10 = 1
So 27934-98-1 is a valid CAS Registry Number.
InChI:InChI=1/C17H26O11/c1-16(23)3-4-17(24)7(13(22)25-2)6-26-15(12(16)17)28-14-11(21)10(20)9(19)8(5-18)27-14/h6,8-12,14-15,18-21,23-24H,3-5H2,1-2H3/t8-,9-,10+,11-,12-,14?,15+,16+,17+/m1/s1
27934-98-1Relevant articles and documents
BIOSYNTHESIS OF IRIDOID GLUCOSIDES IN HEBENSTRETIA DENTATA
Damtoft, Soeren,Jensen, Soeren Rosendal,Nielsen, Bent Juhl,Thorsen, Jesper
, p. 3839 - 3844 (1992)
Deuterium-labelled samples of 8-epi-iridodial, 8-epi-iridotrial and their glucosides were fed to Hebenstretia dentata.The aglucones were better precursors than their glucosides of ipolamiide and lamiide, the iridoid glucosides of the plant.A feeding experiment with (13)C-labelled 10-hydroxy-geraniol showed that C-3 and C-11 are equivalent during biosynthesis of the iridoid glucosides and, thus, glucosidation must take place after formation of 8-epi-iridotrial.Isolation of the minor metabolites after feeding with 8-epi-deoxyloganic acid suggested that the route from this compound proceeds by oxidation at C-8 followed by esterification and that oxidation at C-5 is the final step. Key Word Index: Hebenstretia dentata; Scrophulariaceae; iridoid glucosides; ipolamiide; lamiide; biosynthesis; (2)H NMR.
